Innovative Pharmaceutical Biotech Limited (HKG:0399)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2050
-0.0070 (-3.30%)
Jun 13, 2025, 4:08 PM HKT

HKG:0399 Revenue

Innovative Pharmaceutical Biotech had revenue of 3.03M HKD in the half year ending September 30, 2024, a decrease of -26.80%. This brings the company's revenue in the last twelve months to 5.90M, down -23.08% year-over-year. In the fiscal year ending March 31, 2024, Innovative Pharmaceutical Biotech had annual revenue of 6.59M, down -18.35%.

Revenue (ttm)
5.90M
Revenue Growth
-23.08%
P/S Ratio
75.33
Revenue / Employee
294.75K
Employees
20
Market Cap
444.07M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20246.59M-1.48M-18.35%
Mar 31, 20238.08M-3.07M-27.55%
Mar 31, 202211.15M-4.04M-26.62%
Mar 31, 202115.19M609.00K4.18%
Mar 31, 202014.58M-4.01M-21.57%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alibaba Group Holding 1,068.25B
BYD Company 881.88B
Meituan 376.19B
JD.com 1,286.44B
Pop Mart International Group 13.87B
Trip.com Group 59.20B
ANTA Sports Products 75.37B
Li Auto 155.20B
Revenue Rankings